Clearside Biomedical Inc (CLSD)
1.32
+0.01
(+0.76%)
USD |
NASDAQ |
May 17, 16:00
1.32
0.00 (0.00%)
After-Hours: 20:00
Clearside Biomedical 1 Year Total Returns (Daily): 25.96% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 17, 2024 | 25.96% |
| May 16, 2024 | 25.96% |
| May 15, 2024 | 23.36% |
| May 14, 2024 | 21.90% |
| May 13, 2024 | 17.14% |
| May 10, 2024 | 7.76% |
| May 09, 2024 | 25.00% |
| May 08, 2024 | 14.41% |
| May 07, 2024 | 26.73% |
| May 06, 2024 | 26.73% |
| May 03, 2024 | 31.63% |
| May 02, 2024 | 34.71% |
| May 01, 2024 | 27.00% |
| April 30, 2024 | 24.75% |
| April 29, 2024 | 27.72% |
| April 26, 2024 | 27.01% |
| April 25, 2024 | 17.76% |
| April 24, 2024 | 21.82% |
| April 23, 2024 | 29.25% |
| April 22, 2024 | 33.02% |
| April 19, 2024 | 13.91% |
| April 18, 2024 | 17.86% |
| April 17, 2024 | 15.60% |
| April 16, 2024 | 4.55% |
| April 15, 2024 | 17.27% |
| Date | Value |
|---|---|
| April 12, 2024 | 12.61% |
| April 11, 2024 | 4.84% |
| April 10, 2024 | 0.00% |
| April 09, 2024 | 4.03% |
| April 08, 2024 | 4.03% |
| April 05, 2024 | 5.69% |
| April 04, 2024 | -1.48% |
| April 03, 2024 | 33.64% |
| April 02, 2024 | 34.62% |
| April 01, 2024 | 51.92% |
| March 28, 2024 | 64.53% |
| March 27, 2024 | 75.79% |
| March 26, 2024 | 74.23% |
| March 25, 2024 | 78.35% |
| March 22, 2024 | 69.31% |
| March 21, 2024 | 76.47% |
| March 20, 2024 | 67.70% |
| March 19, 2024 | 56.73% |
| March 18, 2024 | 50.00% |
| March 15, 2024 | 74.49% |
| March 14, 2024 | 67.96% |
| March 13, 2024 | 55.24% |
| March 12, 2024 | 51.85% |
| March 11, 2024 | 87.04% |
| March 08, 2024 | 35.77% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-92.30%
Minimum
May 30 2019
371.7%
Maximum
Sep 24 2021
17.68%
Average
-7.21%
Median
Nov 28 2023
1 Year Total Returns (Daily) Benchmarks
| Cassava Sciences Inc | -8.58% |
| Heron Therapeutics Inc | 156.0% |
| Actinium Pharmaceuticals Inc | 16.81% |
| Karyopharm Therapeutics Inc | -53.06% |
| Ocular Therapeutix Inc | -3.29% |